Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
OTC Chitosan Gel (ANX-011): A Nasal Gel Formulation for Cold and Flu Treatment that is Commercially Ready More
Development of a Novel Treatment of Bedsores and Other Dermal Ulcers: A Spray Formulation Containing Recombinant Human Basic Fibroblast Growth Factor More
Virosome Technology: Target-Specific Delivery of Antigens and Amplification of the Immune Response More
Transdermal Delivery System for an Antigen More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 11 pages - $500
Mar 2010 - 414 pages - $690
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Feb 2009 - 242 pages - $690
Jun 2011 - 16 pages - $500
Oct 2010 - 59 pages - $1,000
Apr 2010 - 23 pages - $99
May 2011 - 10 pages - $500
Apr 2010 - 5 pages - $500
Your selection
Browse By
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us